Stifel raised the firm’s price target on Xylem (XYL) to $178 from $175 and keeps a Buy rating on the shares after the company reported “strong” Q3 results, driven by both margin expansion and 7% organic revenue growth. The firm believes simplification initiatives are gaining traction and looks for growth initiatives to get more focus going forward, the analyst says.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XYL: